Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

Webinar | Generic Drug Labeling, Product Liability, and the Changing FDA Regulatory Landscape

By HL Pharmaceutical & Biotechnology Team on March 7, 2014
Email this postTweet this postLike this postShare this post on LinkedIn

Berkley Life Sciences, Hogan Lovells, and Bowman and Brooke would like to invite you to a 60-minute webinar on Generic Drug Labeling, Product Liability, and the Changing FDA Regulatory Landscape.

The webinar will take place Tuesday, March 11, 2014 at 2:00 p.m. ET.

To register, please click here.

Continuing education
 
Pending CLE certification:
This program is pending approval for CLE credit in New York and California. For all other jurisdictions, attendees will receive a Uniform Certificate of Attendance.

Note to NY Lawyers:
This program is appropriate for non-transitional lawyers, but not acceptable for newly admitted lawyers.

For any questions regarding this event, please contact Kristen Walker.

For the latest government regulatory developments please visit us at Focus on Regulation at www.hlregulation.com

  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Focus on Regulation
  • Organization:
    Hogan Lovells
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
  • About LexBlog
  • The Field We Built
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo